Previously, Di Giacinto et al.[17] showed that administration of the probiotic VSL#3 during the remission period of TNBS-induced colitis increases the numbers of regulatory CD4+LAP+ T cells, and this is essential to the protective effect of the probiotic. This evidence concerns the gene CD4 and colitis.